We are live on ! Find out more
ACP

Ashfield Capital Partners Portfolio holdings

AUM $1.19B
1-Year Est. Return 14.56%
This Fund
S&P 500
This Quarter Est. Return
+11.59%
1 Year Est. Return
-14.56%
3 Year Est. Return
+48.8%
5 Year Est. Return
+97.38%
10 Year Est. Return
AUM
$1B
AUM Growth
+$81.3M
Cap. Flow
-$13M
Cap. Flow %
-1.29%
Top 10 Hldgs %
29.76%
Holding
238
New
6
Increased
36
Reduced
129
Closed
6

Top Buys

Rank Stock Value
1
IQV icon
IQVIA
IQV
+$2.92M
2
INTC icon
Intel
INTC
+$2.24M
3
FISV
Fiserv Inc
FISV
+$1.97M
4
V icon
Visa
V
+$1.1M
5
BMY icon
Bristol-Myers Squibb
BMY
+$913K

Sector Composition

Rank Sector Weight
1 Technology 25.75%
2 Healthcare 16.49%
3 Industrials 10.13%
4 Consumer Discretionary 9.74%
5 Communication Services 7.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WFC icon
51
Wells Fargo
WFC
$261B
$5.23M 0.52%
97,186
-109
-0.1% -$5.71K
AWK icon
52
American Water Works
AWK
$26.7B
$5.05M 0.5%
41,097
-338
-0.8% -$41K
SWK icon
53
Stanley Black & Decker
SWK
$14.3B
$4.99M 0.5%
30,088
-65
-0.2% -$10.1K
SYK icon
54
Stryker
SYK
$125B
$4.92M 0.49%
23,429
-320
-1% -$66.4K
XOM icon
55
ExxonMobil
XOM
$644B
$4.92M 0.49%
70,433
-710
-1% -$49.1K
LIN icon
56
Linde
LIN
$221B
$4.82M 0.48%
22,618
-830
-4% -$167K
IBB icon
57
iShares Biotechnology ETF
IBB
$9.34B
$4.76M 0.47%
39,500
-4,404
-10% -$491K
RTX icon
58
RTX Corp
RTX
$290B
$4.66M 0.46%
49,412
+968
+2% +$87.8K
ADP icon
59
Automatic Data Processing
ADP
$106B
$4.59M 0.46%
26,942
-945
-3% -$156K
VXUS icon
60
Vanguard Total International Stock ETF
VXUS
$155B
$4.48M 0.45%
80,453
-3,368
-4% -$181K
ITW icon
61
Illinois Tool Works
ITW
$82.6B
$4.47M 0.45%
24,883
-1,230
-5% -$208K
EXPD icon
62
Expeditors International
EXPD
$22B
$4.46M 0.44%
57,159
-687
-1% -$51.5K
AXP icon
63
American Express
AXP
$227B
$4.38M 0.44%
35,154
-397
-1% -$47.4K
PXD
64
DELISTED
Pioneer Natural Resource Co.
PXD
$4.22M 0.42%
27,854
-119
-0.4% -$15.8K
BA icon
65
Boeing
BA
$171B
$4.19M 0.42%
12,852
-2,181
-15% -$772K
TJX icon
66
TJX Companies
TJX
$174B
$4.18M 0.42%
68,526
-487
-0.7% -$28.8K
PYPL icon
67
PayPal
PYPL
$48.9B
$4.15M 0.41%
38,353
-279
-0.7% -$29.1K
SIMO icon
68
Silicon Motion
SIMO
$8.6B
$4.08M 0.41%
80,453
-650
-0.8% -$27.9K
HSIC icon
69
Henry Schein
HSIC
$9.77B
$4.05M 0.4%
60,705
-677
-1% -$44.8K
GSEW icon
70
Goldman Sachs Equal Weight US Large Cap Equity ETF
GSEW
$1.89B
$3.95M 0.39%
77,839
-9
-0% -$438
ETFC
71
DELISTED
E*Trade Financial Corporation
ETFC
$3.74M 0.37%
82,510
-3,655
-4% -$156K
PFE icon
72
Pfizer
PFE
$143B
$3.6M 0.36%
96,962
-7,629
-7% -$272K
WELL icon
73
Welltower
WELL
$169B
$3.52M 0.35%
43,102
+155
+0.4% +$13.3K
AFL icon
74
Aflac
AFL
$64.9B
$3.43M 0.34%
64,829
-30
-0% -$1.59K
IQV icon
75
IQVIA
IQV
$38.7B
$3.42M 0.34%
22,126
+19,976
+929% +$2.92M

Similar funds

Ashfield Capital Partners's Q4 2019 Portfolio in Review

As of Q4 2019, Ashfield Capital Partners held 238 positions worth $1B, up 8.8% from $923M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Ashfield Capital Partners's Q4 2019 filing shows 6 new, 36 increased, 129 reduced and 6 closed positions. Its largest new stake was iShares Core S&P Small-Cap ETF: 2,550 shares worth $214K. The largest sale was Celgene Corp, an estimated $4.31M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Industrials.

  • Ashfield Capital Partners's largest Q4 2019 buy was iShares Core S&P Small-Cap ETF: 2,550 shares worth $214K.
  • Ashfield Capital Partners added most to IQVIA in Q4 2019, an estimated $2.92M increase.
  • Ashfield Capital Partners's biggest Q4 2019 reduction was Cisco, cutting an estimated $2.34M.
  • Ashfield Capital Partners fully exited Celgene Corp in Q4 2019, selling an estimated $4.31M.
  • Ashfield Capital Partners's ten largest holdings make up 30% of its $1B portfolio in Q4 2019.
  • Ashfield Capital Partners opened 6 new positions and closed 6 in Q4 2019.
  • Ashfield Capital Partners's portfolio value rose 8.8% quarter-over-quarter to $1B.

Based on Ashfield Capital Partners's 13F filing for Q4 2019, filed 7 Feb 2020.